Showing 1,581 - 1,600 results of 9,300 for search 'significantly ((((((lower decrease) OR (we decrease))) OR (teer decrease))) OR (linear decrease))', query time: 0.51s Refine Results
  1. 1581
  2. 1582
  3. 1583
  4. 1584

    Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

    Published 2024
    “…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”
  5. 1585

    Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

    Published 2024
    “…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”
  6. 1586

    DataSheet1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.pdf by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  7. 1587
  8. 1588
  9. 1589
  10. 1590
  11. 1591
  12. 1592
  13. 1593

    Stepped wedge cluster randomized trial design. by Antonio Marty Quispe (12574259)

    Published 2025
    “…Installing ceiling-mounted mosquito nets in houses has been proposed as a strategy to reduce mosquito–human contact and, in turn, lower malaria transmission. We aimed to assess the effectiveness of ceiling-mounted mosquito nets in reducing Anopheles mosquito density in a high-transmission Amazonian setting. …”
  14. 1594

    Characteristics of JIA patients. by Yasmine Makhlouf (17409866)

    Published 2025
    “…Following biologic therapy, growth delay decreased to 8% and impaired growth to 36.8%. Patients with systemic JIA showed lower changes in growth parameters compared to others, and no significant differences were observed between different biologic drugs. …”
  15. 1595

    List of excluded articles. by Yasmine Makhlouf (17409866)

    Published 2025
    “…Following biologic therapy, growth delay decreased to 8% and impaired growth to 36.8%. Patients with systemic JIA showed lower changes in growth parameters compared to others, and no significant differences were observed between different biologic drugs. …”
  16. 1596

    Table 1_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.xlsx by Erman Wu (19021269)

    Published 2025
    “…Children under 5 years of age group still accounted for the most PMP-related deaths, with the number decreasing from 851,458 (95% UI: 211,026 to 1,363,810) in 1990 to 201,078 (95% UI:61,817 to 337,232). …”
  17. 1597

    Bivariate analysis results. by Oejin Shin (20855617)

    Published 2025
    “…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …”
  18. 1598

    Sequence analysis results. by Oejin Shin (20855617)

    Published 2025
    “…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …”
  19. 1599

    Descriptive analysis. by Oejin Shin (20855617)

    Published 2025
    “…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …”
  20. 1600

    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”